AuNRs-PPARγmAb通过光热效应诱导向脂肪细胞亡,以有效地局部减少脂肪
Yiping Hu1, Kui Xiao1, Ziang Chen1
1Department of Burns and Plastic Surgery, Guangzhou Red Cross Hospital, Jinan University, Guangzhou, Guangdong, 510000, People's Republic of China.
International journal of nanomedicine
|August 7, 2025
概括
这项研究介绍了一种新的纳米平台,将金纳米棒 (AuNR) 与PPARγ单克隆抗体 (PPARγmAb) 结合起来,用于有针对性的非侵入性减肥. 治疗有效地减少脂肪细胞和肥胖小鼠的脂肪,副作用最小,显示临床应用的希望.
科学领域:
- 生物医学工程 生物医学工程
- 纳米技术纳米技术
- 整形外科 整形外科 整形外科
背景情况:
- 非侵入性减肥技术正在进步,但机制和有效性仍在争论中.
- 已知用于癌症治疗的金纳米棒 (AuNRs) 在减肥方面具有尚未开发的潜力.
- 这项研究介绍了一种用于光热减脂疗法的新型纳米平台.
研究的目的:
- 设计和评估一种新的纳米平台,将AuNR与PPARγ单克隆抗体 (PPARγmAb) 结合起来.
- 评估这个纳米平台对光热减脂的有效性和生物相容性.
主要方法:
- AuNRs与PPARγmAb.Ab一起功能化.
- 来自脂肪的干细胞被分化为脂肪细胞,并建立了一个肥胖的小鼠模型.
- 细胞和小鼠被AuNRs-PPARγmAb处理,并暴露在808nm近红外 (NIR) 激光照射中.
主要成果:
- AuNRs-PPARγmAb表现出脂肪细胞中增强的保留和更强的光热效应,诱导了亡.
- 在肥胖小鼠中观察到脂肪组织重量,尺寸和厚度的显著减少.
- 没有发现主要的组织病理损伤或血液学/器官功能参数的变化,证实了生物相容性.
结论:
- AuNRs-PPARγmAb纳米平台有效地通过NIR激光照射准脂肪细胞进行光热减脂.
- 这种有针对性的方法提供了一个有希望的,最少的侵入性和特定的方法,用于局部减肥,副作用较少.
- 该纳米平台显示出在非手术身体轮中临床应用的巨大潜力.
更多相关视频
09:52Investigation of Beige Fat Biology and Metabolism Using the CRISPR SunTag-p65-HSF1 Activation System
Published on: January 6, 2023
2.4K
03:58Generation of Brown Fat-Specific Knockout Mice Using a Combined Cre-LoxP, CRISPR-Cas9, and Adeno-Associated Virus Single-Guide RNA System
Published on: March 24, 2023
2.6K
相关概念视频
02:57Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
01:31The Intrinsic Apoptotic Pathway
Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...